Shire plans filing for HAE drug after phase 3 success
Lanadelumab could revolutionise treatment of swelling disease.
X
Shire plans filing for HAE drug after phase 3 success
https://pharmaphorum.com/news/shire-plans-filing-hae-drug-phase-3-success/
